
| Salt Composition: | Olmesartan Medoxomil (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg) |
| Manufacturer: | Wynclark Pharmaceuticals Private Limited |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Triolmewyn 40mg/5mg/12.5mg Tablet is a combination of medicines used to treat hypertension (high blood pressure) when a single medication is not effective. Triolmewyn 40mg/5mg/12.5mg Tablet is a combination of medicines used to treat hypertension (high blood pressure) when a single medication is not effective. It helps to lower high blood pressure thus reduces chances of future heart attack and stroke.
Triolmewyn 40mg/5mg/12.5mg Tablet is a combination of three medicines: Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide. Olmesartan Medoxomil is an angiotensin receptor blocker (ARB) and Amlodipine is a calcium channel blocker (CCB). They work by widening and relaxing the blood vessels thereby lowering blood pressure. Hydrochlorothiazide is a diuretic which removes extra water and certain electrolytes from the body through urine. Over time it also works by relaxing blood vessels and improving blood flow.
Can I experience dizziness after taking Triolmewyn 40mg/5mg/12.5mg Tablet?
Yes, using Triolmewyn 40mg/5mg/12.5mg Tablet can cause dizziness. Sudden changes in posture from lying or sitting may contribute to this side effect. To minimize the risk of dizziness or fainting, it's essential to gradually change positions when rising.
Can I use Triolmewyn 40mg/5mg/12.5mg Tablet during pregnancy?
No, Triolmewyn 40mg/5mg/12.5mg Tablet should not be used during pregnancy as it may pose a risk to the developing baby. If you become pregnant while taking this medication, stop using it immediately and contact your doctor. The doctor may recommend alternative methods to manage blood pressure.
What lifestyle changes can I make when using Triolmewyn 40mg/5mg/12.5mg Tablet?
Implementing certain lifestyle adjustments can improve your overall health while taking Triolmewyn 40mg/5mg/12.5mg Tablet. Smoking cessation is crucial as it elevates the risk of heart attack and stroke. If you are overweight or obese, aim to lose weight through healthy dietary choices such as adding fruits and vegetables to your meals. Regular physical activity can improve cardiovascular function and reduce the likelihood of experiencing heart attacks.
How do I know if my potassium levels are high?
Your doctor will regularly check your blood potassium levels during treatment to identify high potassium levels. Remember to attend all scheduled medical appointments for this purpose.
Can I stop taking Triolmewyn 40mg/5mg/12.5mg Tablet if I feel well?
No, continue using Triolmewyn 40mg/5mg/12.5mg Tablet as prescribed by your doctor even when you feel well. Abruptly stopping the medication may trigger serious complications such as heart attacks and strokes.
What are the instructions for storing and disposing of Triolmewyn 40mg/5mg/12.5mg Tablet?
Store this medicine in its original, sealed packaging to maintain its integrity. Follow any instructions on the label regarding storage conditions. Dispose of unused medication following recommended guidelines. Ensure it is not accessible to children, pets, or others.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Triolmewyn 40mg/5mg/12.5mg Tablet may be taken with or without food but it is better to take it at a fixed time.
Alcohol
It is unsafe to consume alcohol with Triolmewyn 40mg/5mg/12.5mg Tablet.
Breastfeed
Triolmewyn 40mg/5mg/12.5mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Triolmewyn 40mg/5mg/12.5mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.